前沿论文｜CELL INTELLIGENCE

Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets.

PubMed 2026/08/10 发表Future Sci OAQ3 · IF 2.5（JCR 2025）

Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.

PubMed 2026/04/09 发表Nat CommunQ1 · IF 18.1（JCR 2025）

CAR-T/NK/M-based combination therapies in cancer: A comprehensive review.

PubMed 2026/01/20 发表Curr Probl CancerQ3 · IF 2.4（JCR 2025）

Multiparametric Detection of Effects of TILs and Oncolytic Virotherapy on Xenograft Mouse Model of Glioblastoma.

PubMed 2025/12/04 发表BiomedicinesQ2 · IF 4.5（JCR 2025）

Shaping the glioblastoma microenvironment to enhance CAR-NK immunotherapy.

PubMed 2025/12/01 发表Front ImmunolQ1 · IF 7（JCR 2025）

From Bench to Bedside: Emerging Paradigms in CAR-T Cell Therapy for Solid Malignancies.

PubMed 2025/08/25 发表Adv Sci (Weinh)Q1 · IF 14.1（JCR 2025）

Therapeutic approaches to modulate the immune microenvironment in gliomas.

PubMed 2024/10/23 发表NPJ Precis OncolQ1 · IF 9.9（JCR 2025）

Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma.

PubMed 2023/12/15 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma.

PubMed 2023/08/12 发表J Clin MedQ1 · IF 3.3（JCR 2025）

前沿论文 9